Literature DB >> 11305574

Pulmonary MALT lymphoma: imaging findings in 24 cases.

L J King1, S P Padley, A C Wotherspoon, A G Nicholson.   

Abstract

The aim of this study was to describe the imaging features of pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma. The chest radiographs (n = 18) and CT scans (n = 17) of 24 patients (18 men and 6 women) aged 27-78 years (mean = 56 years), with a known diagnosis of pulmonary MALT lymphoma, were retrospectively reviewed by two radiologists and the imaging findings are described. Six of the 24 patients had a history of an autoimmune disorder and 1 patient had acquired immune deficiency syndrome. Multiple pulmonary lesions were identified in 19 of 24 patients (79%) and solitary lesions in 4 of 24 patients (17%). Diffuse pulmonary infiltration was present in 1 patient. Lesions included masses or mass-like areas of consolidation (n = 21) and pulmonary nodules (n = 18). Associated findings were air bronchograms, airway dilatation, a positive angiogram sign and a halo of ground-glass shadowing at lesion margins. Peribronchovascular thickening was also observed, as were hilar or mediastinal lymph node enlargement and pleural effusions or thickening. Although rare, the diagnosis of pulmonary MALT lymphoma should be considered in patients with the imaging features described, particularly when in association with an indolent clinical course or a history of autoimmune disease.

Entities:  

Mesh:

Year:  2000        PMID: 11305574     DOI: 10.1007/s003300000491

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  20 in total

1.  Multiple cystic lung lesions and autoimmune thrombocytopaenia developing after chemotherapy for pulmonary indolent B-cell lymphoma with plasmacytic differentiation.

Authors:  Hiroaki Tanaka; Chihiro Kuwabara; Yusuke Isshiki; Yoshio Suzuki
Journal:  BMJ Case Rep       Date:  2018-12-13

Review 2.  The radiological spectrum of pulmonary lymphoproliferative disease.

Authors:  S S Hare; C A Souza; G Bain; J M Seely; M M Gomes; M Quigley
Journal:  Br J Radiol       Date:  2012-07       Impact factor: 3.039

3.  Pulmonary mucosa-associated lymphoid tissue lymphoma: 18F-FDG PET/CT and CT findings in 28 patients.

Authors:  Domenico Albano; Andrea Borghesi; Giovanni Bosio; Mattia Bertoli; Roberto Maroldi; Raffaele Giubbini; Francesco Bertagna
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

Review 4.  The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.

Authors:  Sarah P Georgiadou; Nikolaos V Sipsas; Edith M Marom; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

Review 5.  [Radiological diagnostics of Hodgkin- and non-Hodgkin lymphomas of the thorax].

Authors:  M Uffmann; C Schaefer-Prokop
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

6.  Comparisons of Surgery and/or Chemotherapy in the Treatment of Primary Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma.

Authors:  Bo Wang; Chengwei Zhang; Bin Wang; Lianbin Zhang
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-08-29       Impact factor: 1.520

7.  Primary pulmonary lymphoma: imaging findings in 30 cases.

Authors:  Diletta Cozzi; Catia Dini; Francesco Mungai; Benedetta Puccini; Luigi Rigacci; Vittorio Miele
Journal:  Radiol Med       Date:  2019-10-03       Impact factor: 3.469

8.  Decision-making in diagnosis of bronchus-associated lymphoid tissue lymphoma.

Authors:  Tasnim Lat; Juan F Sanchez; Meghan K McGraw; Parsa Hodjat; Heath D White; Carl D Boethel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-03-09

9.  HRCT in primary pulmonary lymphoma: can CT imaging phenotypes differentiate histological subtypes between mucosa-associated lymphoid tissue (MALT) lymphoma and non-MALT lymphoma?

Authors:  Yinan Chen; Aiping Chen; Hailin Jiang; Yuxuan Zhang; Lin Zhu; Chunyan Xia; Hong Yu
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

10.  Development of Bullous Disease during Treatment of Pulmonary Marginal Zone B-Cell Lymphoma.

Authors:  S Ansari; H Dubaybo; E Levi; B A Dubaybo
Journal:  Case Rep Pulmonol       Date:  2012-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.